International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 3 | Views: 61 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Case Studies | Medicine | Iraq | Volume 13 Issue 3, March 2024 | Rating: 5.2 / 10

Evaluation of Adherence to Methotrexate in a Sample of Iraqi Patients with Rheumatoid Arthritis Receiving Anti - TNF Medications

Ziad S. Al - Rawi | Sumaya Abdulhassan Abdulkareem | Elaf Ayyed Jebur

Abstract: Background: Rheumatoid arthritis is a chronic inflammatory disease. Current treatment guidelines for RA recommend early aggressive management with Disease - modifying antirheumatic drugs. Non - adherence to treatment has been associated with symptom worsening and increased disability. Aim of study: to determine the prevalence level and factors that affect adherence to Methotrexate among Rheumatoid arthritis patients receiving Anti - Tumor Necrosis Factor. Patients & Methods: This cross - sectional study included a total of 100 patients diagnosed as Rheumatoid arthritis according to ACR / EULAR, 2010 criteria. The enrolled patients answered an interview questionnaire regarding socio - demographic, clinical and treatment information survey including the Arabic version of the eight - item Morisky Medication Adherence Scale. Results: According to Morisky scale, 54% of Rheumatoid arthritis patients taking Anti - TNF medications were classified as having low adherence to Methotrexate therapy. During multivariate analysis, Older age patients >45 (p= 0.004), illiteracy (p=0.028), low socioeconomic state (p=0.050), disease duration >10 years (p=0.008), Methotrexate use duration >5 years (p=0.013), Anti - TNF use duration >3 years (p=0.001), presence of side effects (P= 0.025), non - self dependent (P=0.020), and moderate disease activity (P=0.043) were significantly independent risk factors for non - adherence to Methotrexate. Conclusions: Fifty four percent of patients who are using Anti - TNF were classified as low adherent to Methotrexate. Older age >45 years, illiteracy, low socioeconomic state, disease duration >10 years, Methotrexate duration use >5 years, Anti - TNF duration use >3 years, presence of side effects, non - self dependent, and moderate disease activity were significantly independent risk factors for non - adherence.

Keywords: Rheumatoid Arthritis, Anti - TNF Medications, Methotrexate Adherence

Edition: Volume 13 Issue 3, March 2024,

Pages: 1127 - 1136

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait